SEM — Select Medical Holdings Corp · catalysts, narrative & risks

Status note (point-in-time: 2026-10-30)

As of October 30, 2026, Select Medical Holdings Corp (NYSE: SEM) is no longer a publicly traded stock. A consortium led by co-founder/Executive Chairman Robert A. Ortenzio, Senior EVP Martin F. Jackson, and private-equity sponsor Welsh, Carson, Anderson & Stowe (WCAS) completed its acquisition on June 30, 2026, and the stock was delisted and marked inactive at a last trade of $16.51 on June 30, 2026 ([10], [13], [14]). Public shareholders were to receive $16.50 per share in cash ([1]). Below is a reconstruction of the recent catalysts, narratives, and risks, with the take-private transaction as the dominant theme.

Recent catalysts (last ~1–3 months; July–October 2026)